No Detail Found!

Efficacy of 17-a-hydroxy-progestrone in Prevention of Preterm Labour in High Risk Pregnant Women.

Author(s)
Wajiha Shadab Islamic International Medical College, Islamabad,
Shazia Riaz Islamic International Medical College, Islamabad,
Farzana Aftab Rawal Institute of Health Sciences, Islamabad,
Faizan Hassan Shah Ayub Teaching Hospital, Abbottabad, Pakistan
Abstract
Background: Preterm delivery (before 37 completed weeks of gestation) is a major determinant of infant mortality. The objective of study was to determine the efficacy of 17-alpha hydroxyprogesterone in preventing delivery before 37 weeks of gestation in high risk women. Methods: This study, a randomized controlled trial was conducted in Obstetrics OPD, observing all scientific and ethical protocols. The women with less than 20 weeks gestation and with a past history of preterm delivery were included. A total of 132 women fulfilled the study requirements. Two groups made were as follows: Group A (Treatment group received intramuscular 17-alpha hydroxy-progesterone) and Group B served as control (The control group revived intramuscular Neurobion). A total of 66 women were assigned to each group. The data was recorded on a specially designed proforma for statistical analysis and comparison following the standard procedure. Results: The criterion was strictly observed. The results showed a statistically significant (p<0.01) difference between group A as compared to group B. Conclusion: 17-aHydroxyprogesterone was found to be an effective drug in preventing delivery before 37 weeks in women at risk.
Publication Details
Page(s) 209-212
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 30, Issue: 2, Year: 2018

Request the full text from PASTIC

Keywords
NULLL
References
ButlerAS,BehrmanRE,,2007,,Preterm birth: causes,,-
RushRW,DaveyDA,SegallML,,1978,The effect of preterm delivery on perinatal mortality,Br J Obstet Gynaecol,85,806-11
NelsonDB,McIntireDD,McDonaldJ,GardJ,TurrichiP,LevenoKJ,,2017,-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study,Am J Obstet Gynecol,216,e600-1
O'Brien,JM , Adair,CD , Lewis,DF , Hall,DR , Defranco,EA , Fusey,S,,2007,Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial,Ultrasound Obstet Gynecol,30,687-96
BittarER,YamasakiAA,SasakiS,ZugaibM.,,1996,Cervical fetal fibronectina in patients at increased risk for preterm delivery,Am J Obstet Gynecol,175,178-81
CunninghamFG,GantNF,LevenoKJ,GilstrapIII LC,HauthJC,WenstromKD,Prentice-Hall International,,1997,Preterm and postterm pregnancy and fetal growth retardation,,,797-826
ErnyR,PigneA,ProuvostC,GamerreM,MaletC,SermentH,,1986,The effects of oral administration of progesterone for premature labor,Am J Obstet Gynecol,154,525-9
CheckJH,LeeG,EpsteinR,VetterB,,1992,Increased rate of preterm deliveries in untreated women with luteal phase deficiencies,Gynecol Obstet Invest,33,183-4
LockwoodCJ,SenyeiAE,DischieMR,CasalD,ShahKD,ThugSN,,1991,Fetal fibronectina in cervical and vaginal secretions as a predictor of preterm delivery,N Engl J Med,325,669-74
MichalA,Elovitz , MD,ConjecvarmM.,,2006,The use of progestational agents for preterm birth: lessons from a mouse model,Am J Obstet Gynecol,195,1004-10
,2017,The choice of progestogen for the prevention of preterm birth in women with singleton pregnancy and prior preterm birth,Am J Obstet Gynecol,216,B11-3
RomeroR,YeoL,MirandaJ,HassanSS,Conde-AgudeloA,ChaiworapongsaT.,,2013,A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix,J Perinat Med,41,27-44
PanethNS,,1995,The problem of low birth weight,Future Child,5,19-34
MattisonDR,DamusK,FioreE,PetriniJ,AlterC,,2001,Preterm delivery: a public health perspective,Paediatr Perinat Epidemiol,15,7-16
CreasyRK,,1993,Preterm birth prevention: where are we?,Am J Obstet Gynecol,168,1223-30
JohnsonJW,AustinKL,JonesGS,DavisGH,KingTM,,1975,Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor,N Engl J Med,293,675-80
HauthJC,GilstrapLC,BrekkenAL,HauthJM,,1983,The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population,Am J Obstet Gynecol,146,187-90
HobelCJ,RossMG,BemisRL,BragonierJR,NessimS,SandhuM,,1994,Program impact on high-risk women,Am J Obstet Gynecol,170,54-62
FuchsF,StakemannG,,1960,Treatment of threatened premature labor with large doses of progesterone,Am J Obstet Gynecol,79,172-6
FuchsAR,FuchsF,,1984,Endocrinology of human parturition: a review,Br J Obstet Gynaecol,91,948-67
,2003,American college of obstetricians and gynaecologists. ACOG committee opinion: use of progesterone to reduce preterm birth,Obstet Gynecol,102,1115-6
RittenbergC,NewmanRB,IstwanNB,RheaDJ,StanzianoGJ,,2009,Preterm birth prevention by 17 alphahydroxyprogesteronecaproate vs,Daily Nursing Surveillance. J Reprod Med,54,47-52
0

Citations

0

Downloads

106

Views